Epsilon M&A Deal Report - Non-Core OTC Brands of GlaxoSmithKline
Transaction Multiples for the Valuation of Private Companies
Omega Pharma / Non-Core OTC Brands of GlaxoSmithKline
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Food Producers > Food & Beverage Industry > Food Complements
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
||||||
Current |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
- Number of EMAT Reports / sub-sector « Food Complements » = 122
Date | Acquirer | Target | Country | Multiples | See details |
31/05/2016 | Recordati | Italchimici | Italy | ** | 80426 |
17/05/2016 | Private Group led by Vertis SGR | Preziosi Food | Italy | ** | 80377 |
Source: Epsilon Research / EMAT